Momordica Charantia and Dihydroartemisinin-piperaquined-primaquine for Uncomplicated Plasmodium Falciparum Malaria Patients in Southwest Sumba Regency
Conditions: Parasitemia; Clinical Malaria; Immune Tolerance Interventions: Drug: Dihydroartemisinin; Drug: Piperaquine; Drug: Primaquine; Drug: Momordica Charantia Extract Sponsor: Syamsudin Abdillah,Ph.D, Pharm D Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials